$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
Walgreens (WBA) Expands Access to COVID-19 Test With LabCorp
09:02am, Tuesday, 08'th Mar 2022
Walgreens (WBA) will enable more communities to access reliable, convenient testing services as and when required with the addition of Pixel by LabCorp COVID-19 at-home collection kit.
Is John Hancock Multifactor Mid Cap ETF (JHMM) a Strong ETF Right Now?
11:20am, Friday, 04'th Mar 2022 Zacks Investment Research
Smart Beta ETF report for JHMM
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?
11:20am, Friday, 18'th Feb 2022 Zacks Investment Research
Style Box ETF report for JHMM
LabCorp (LH) Expands Clinical Laboratory Services With New Pact
12:49pm, Tuesday, 15'th Feb 2022 Zacks Investment Research
LabCorp's (LH) recent collaboration will enable it to administer Ascension's hospital-based laboratories in 10 states and purchase select assets of the health system's outreach laboratory business.
LabCorp (LH) Expands Clinical Laboratory Services With New Pact
09:15am, Tuesday, 15'th Feb 2022
LabCorp's (LH) recent collaboration will enable it to administer Ascension's hospital-based laboratories in 10 states and purchase select assets of the health system's outreach laboratory business.
Expert Ratings For Laboratory Corp
02:13pm, Monday, 14'th Feb 2022 Benzinga
Over the past 3 months, 6 analysts have published their opinion on Laboratory Corp (NYSE:LH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a com
Expert Ratings For Laboratory Corp
02:13pm, Monday, 14'th Feb 2022 Benzinga
Over the past 3 months, 6 analysts have published their opinion on Laboratory Corp (NYSE: LH ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company''s business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 4 1 0 0 Last 30D 0 1 0 0 0 1M Ago 0 1 1 0 0 2M Ago 1 1 0 0 0 3M Ago 0 1 0 0 0 In the last 3 months, 6 analysts have offered 12-month price targets for Laboratory Corp. The company has an average price target of $345.33 with a high of $380.00 and a low of $294.00. Below Full story available on Benzinga.com
Laboratory Corporation of America (LH) Q4 2021 Earnings Call Transcript
08:00pm, Thursday, 10'th Feb 2022 The Motley Fool
LH earnings call for the period ending December 31, 2021.
Laboratory Corporation of America (LH) Q4 2021 Earnings Call Transcript
08:00pm, Thursday, 10'th Feb 2022 The Motley Fool
LH earnings call for the period ending December 31, 2021.
Laboratory Corporation of America Holdings (LH) CEO Adam Schechter on Q4 2021 Results - Earnings Call Transcript
06:12pm, Thursday, 10'th Feb 2022 Seeking AlphaLabCorp (LH) Q4 Earnings Surpass Estimates, Margins Down
04:04pm, Thursday, 10'th Feb 2022 Zacks Investment Research
LabCorp (LH) reports better-than-expected results for the fourth quarter, with solid contributions from the Drug Development business driving the top line.
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
01:29pm, Thursday, 10'th Feb 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Merck Announces Publication Of Positive Late-Stage Data For Keytruda-Chemo Combo In Breast Cancer
Merc
Laboratory Corporation of America Holdings (LH) CEO Adam Schechter on Q4 2021 Results - Earnings Call Transcript
01:12pm, Thursday, 10'th Feb 2022
Laboratory Corporation of America Holdings (LH) CEO Adam Schechter on Q4 2021 Results - Earnings Call Transcript
LabCorp up 4% following quarterly earnings beat
01:04pm, Thursday, 10'th Feb 2022 Seeking Alpha
Shares of Laboratory Corporation of America are trading 8% higher this morning after the company Q4 2021 results beat on both the top and bottom lines.
LabCorp (LH) Q4 Earnings Surpass Estimates, Margins Down
12:19pm, Thursday, 10'th Feb 2022
LabCorp (LH) reports better-than-expected results for the fourth quarter, with solid contributions from the Drug Development business driving the top line.
Sign In
Buy LH